AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Campbell, JDM Cook, G Holyoake, TL
Citation: Jdm. Campbell et al., Evolution of bone marrow transplantation - the original immunotherapy, TRENDS IMMU, 22(2), 2001, pp. 88-92

Authors: Jorgensen, HG Holyoake, TL
Citation: Hg. Jorgensen et Tl. Holyoake, A comparison of normal and leukemic stem cell biology in chronic myeloid leukemia, HEMATOL ONC, 19(3), 2001, pp. 89-106

Authors: Drummond, MW Holyoake, TL
Citation: Mw. Drummond et Tl. Holyoake, Tyrosine kinase inhibitors in the treatment of chronic myeloid leukaemia: so far so good?, BLOOD REV, 15(2), 2001, pp. 85-95

Authors: Glimm, H Eisterer, W Lee, K Cashman, J Holyoake, TL Nicolini, F Shultz, LD von Kalle, C Eaves, CJ
Citation: H. Glimm et al., Previously undetected human hematopoietic cell populations with short-termrepopulating activity selectively engraft NOD/SCID-beta 2 microglobulin-null mice, J CLIN INV, 107(2), 2001, pp. 199-206

Authors: Holyoake, TL Freshney, MG Samuel, K Ansell, J Watson, GE Wright, EG Graham, GJ Pragnell, IB
Citation: Tl. Holyoake et al., In vivo expansion of the endogenous B-cell compartment stimulated by radiation and serial bone marrow transplantation induces B-cell leukaemia in mice, BR J HAEM, 114(1), 2001, pp. 49-56

Authors: Holyoake, TL
Citation: Tl. Holyoake, Recent advances in the molecular and cellular biology of chronic myeloid leukaemia: Lessons to be learned from the laboratory, BR J HAEM, 113(1), 2001, pp. 11-23

Authors: Holyoake, TL Jiang, XY Jorgensen, HG Graham, S Alcorn, MJ Laird, C Eaves, AC Eaves, CJ
Citation: Tl. Holyoake et al., Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association with up-regulation of expression of interleukin-3, BLOOD, 97(3), 2001, pp. 720-728

Authors: Holyoake, TL Horrocks, C Thomas, T Eaves, CJ Eaves, AC
Citation: Tl. Holyoake et al., Cell separation improves the sensitivity of detecting rare human normal and leukemic hematopoietic cells in vivo in NOD/SCID mice, CYTOTHERAPY, 2(6), 2000, pp. 411-421

Authors: Brummendorf, TH Holyoake, TL Rufer, N Barnett, MJ Schulzer, M Eaves, CJ Eaves, AC Lansdorp, PM
Citation: Th. Brummendorf et al., Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry, BLOOD, 95(6), 2000, pp. 1883-1890

Authors: Holyoake, TL Nicolini, FE Eaves, CJ
Citation: Tl. Holyoake et al., Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow, EXP HEMATOL, 27(9), 1999, pp. 1418-1427

Authors: Nicolini, FE Holyoake, TL Cashman, JD Chu, PPY Lambie, K Eaves, CJ
Citation: Fe. Nicolini et al., Unique differentiation programs of human fetal liver stem cells shown bothin vitro and in vivo in NOD/SCID mice, BLOOD, 94(8), 1999, pp. 2686-2695
Risultati: 1-11 |